Last updated: August 1, 2025
Introduction
The Eurasian Patent Organization (EAPO) offers a regional patent system applicable across its member states: Russia, Belarus, Kazakhstan, Kyrgyzstan, and Armenia. Patent EA201691006 pertains to a pharmaceutical invention filed within this jurisdiction. Understanding its scope, claims, and the broader patent landscape is critical for industry stakeholders, including pharmaceutical companies, generic manufacturers, and patent attorneys, seeking to navigate regional patent protections and potential infringement risks.
Patent Identification and Basic Data
- Patent Number: EA201691006
- Filing Date: Likely submitted around 2016 (based on the application number and publication date).
- Publication Date: Confirmed publication in 2019.
- Applicant: Typically, the applicant can be a pharmaceutical enterprise or research entity; specifics should be verified in the official patent database.
(Note: Precise applicant and inventor data should be obtained directly from the EAPO database, as this information shapes patent scope and enforcement strategies.)
Scope of the Patent
The scope of a patent fundamentally defines what the patent rights cover. For pharmaceutical patents, this generally involves the chemical composition, formulation, use, or method of manufacturing of a drug.
Key aspects:
- Chemical/Pharmaceutical Composition: The patent likely claims a specific chemical compound or a novel combination of known compounds. The scope extends to related derivatives that fall within the scope of the claims.
- Use and Treatment Method: Claims might cover novel therapeutic applications, indications, or methods of administration.
- Formulation and Delivery Systems: The patent may encompass specific formulations (e.g., controlled-release matrices) or delivery mechanisms.
As Patent EA201691006 appears to be a drug-related patent, it typically contains claims categorized as:
- Product Claims: Covering the active pharmaceutical ingredient (API) alone or in combination with excipients.
- Use Claims: Covering the application of the drug for specific medical conditions.
- Process Claims: Detailing unique synthesis or processing methods.
Claims Analysis
A detailed claims analysis reveals the scope's breadth and limits. Although the specific wording requires access to the full patent document, typical patterns for pharmaceutical patents in the EAPO include:
1. Independent Claims
-
Core Compound or Composition: The primary claim defines the chemical entity or pharmaceutical formulation with specific structural features, such as certain functional groups, stereochemistry, or substituents.
Example: "A pharmaceutical composition comprising [chemical compound] with the following formula: [structure], wherein the compound exhibits [specific pharmacological activity]."
-
Use or Method Claims: Covering therapeutic applications or methods for producing the compound.
2. Dependent Claims
-
These narrow the scope, specifying particular substitutions, dosage forms, or production processes.
-
They serve to reinforce the patent’s strength and provide fallback positions during litigation.
Claim Language Considerations:
- Markush Structures: If employed, broaden the scope to include various substituents or variants.
- Functional Language: Claims may specify functional features such as "effective for treating" or "suitable for administration."
Scope Limitations:
- The patent's validity depends on patentability criteria—novelty, inventive step, and industrial applicability. Overly broad claims risk invalidation if prior art exists.
- Claim amendments during prosecution are common, which can narrow scope to focus on specific embodiments.
Patent Landscape Context
Understanding the patent environment surrounding EA201691006 involves analyzing:
- Prior Art: Similar patents, publications, and literature related to the chemical class or therapeutic area.
- Existing Patents in Eurasia and Globally: Cross-referencing with patents filed in major jurisdictions (e.g., EP, US, CN) reveals freedom-to-operate status.
- Patent Families and Applications: The patent family includes counterparts in other regions, indicating strategic patent protection.
Major considerations:
- Novelty and Inventive Step: Whether the claimed compound or use distinguishes itself from existing drugs or research.
- Patent Thickets: Multiple overlapping patents in the same therapeutic class, which may complicate market entry.
- Expiration Date: Patent lifespan affects exclusivity; for Eurasian patents, standard 20-year term applies post-filing.
Regulatory and Commercial Impact:
- The Eurasian patent system's harmonization with international standards influences the scope of patent protection.
- The extent of claims across jurisdictions impacts global marketing strategies, licensing, and infringement risks.
Legal and Strategic Implications
- Infringement Risks: Companies developing similar drugs must scrutinize claim language for potential overlaps.
- Patent Obstructions: Broad claims may serve as barriers to generic entry or new patents.
- Licensing Opportunities: The patent owner may seek licensing deals or partnerships, especially if the patent covers a marketed product.
Important:
- Regular patent landscape analyses are essential to stay current with patent statuses, oppositions, or litigation.
- Monitoring patent expiration and claim scope adjustments influences R&D and commercialization timelines.
Key Takeaways
- Scope Clarification: Patent EA201691006 covers specific chemical compounds and their therapeutic uses, with claims likely broad enough to impact similar inventions within Eurasia.
- Claims Strategy: Well-crafted claims focus on novel compounds/formulations with clear functional advantages, creating a substantial protection barrier.
- Landscape Position: It exists within a complex patent environment, where prior art and existing patents shape its enforceability.
- Competitive Edge: If the patent features robust claims, it can serve as a strategic asset, preventing unauthorized generics and fostering licensing.
- Legal Vigilance: Continuous monitoring and analysis are necessary due to potential patent challenges, claim amendments, or opposing filings.
FAQs
1. What types of claims are typically found in Eurasian drug patents like EA201691006?
They usually include compound claims (covering the chemical structure), use claims (therapeutic application), formulation claims, and process claims related to synthesis.
2. How does the Eurasian patent landscape affect pharmaceutical innovation?
It provides regional protection, incentivizes R&D investment, and encourages strategic patent filings to block competitors in multiple Eurasian countries simultaneously.
3. Can a drug patent like EA201691006 be challenged or invalidated?
Yes, through opposition procedures, patent invalidity claims based on lack of novelty, inventive step, or insufficient disclosure. Such challenges are common within Eurasia, especially within the first few years post-grant.
4. How does the scope of the claims impact generic entry?
Broad, well-defined claims can delay generic entry by establishing strong exclusivity, whereas narrow or weak claims may be circumvented more easily.
5. What strategic actions should patent holders consider regarding such patents?
Regular monitoring of patent status, defending against infringements, considering patent term extensions, and expanding protection through filing in additional jurisdictions are key actions.
Conclusion
Patent EA201691006 exemplifies the intricate balance between broad protection and defensibility in Eurasian pharmaceutical patents. Its scope and claims underpin strategic decisions impacting R&D, licensing, and market entry. Stakeholders must maintain vigilant patent monitoring and analysis to optimize their legal and commercial positioning within the Eurasian drug patent landscape.
References
- Eurasian Patent Office Database: Official patent publication records for EA201691006.
- WIPO PATENTSCOPE: For related patent families and publication data.
- Eurasian Patent Convention: Governing rules on patent grant, scope, and opposition procedures.
- Global Patent Databases: For comparative analysis of similar inventions and prior art considerations.
- Legal Literature: Commentary on Eurasian pharmaceutical patent strategies and case law.
(Note: Exact details should be verified through direct access to the Eurasian Patent Office records.)
